|
Volumn 5, Issue 8 Suppl 12, 2007, Pages
|
Combination treatment approaches and novel therapies for lymphoma.
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIIDIOTYPIC ANTIBODY;
ANTINEOPLASTIC AGENT;
BENDAMUSTINE;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
CANCER VACCINE;
CHLORMETHINE DERIVATIVE;
CYTOKINE;
GALIXIMAB;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
PYRAZINE DERIVATIVE;
RITUXIMAB;
HUMAN;
IMMUNOLOGY;
NONHODGKIN LYMPHOMA;
REVIEW;
STEM CELL TRANSPLANTATION;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CANCER VACCINES;
CYTOKINES;
HUMANS;
IMMUNOLOGIC FACTORS;
LYMPHOMA, NON-HODGKIN;
NITROGEN MUSTARD COMPOUNDS;
PYRAZINES;
STEM CELL TRANSPLANTATION;
|
EID: 38449090547
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (112)
|